Stereotactic Magnetic Resonance Guided Radiation Therapy

  • End date
    Jun 5, 2024
  • participants needed
  • sponsor
    Dana-Farber Cancer Institute
Updated on 5 October 2021
stereotactic body radiation therapy
primary cancer


This is a master prospective Phase I-II trial evaluating feasibility and efficacy of stereotactic magnetic resonance (MR) guided adaptive radiation therapy (SMART) in patients with cancer.

  • The phase 1 study will evaluate the feasibility and safety of delivering SMART in patients with cancer.
  • Phase 2 will evaluate efficacy of SMART with specific reference to tumor control and improvement in patient reported outcome measures


This research study is a feasibility study, which means it is the first-time investigators at this institution are examining this type of MR-guided radiation to treat cancer.

The U.S. Food and Drug Administration (FDA) has approved this device as a treatment option for cancer.

In this research study, the investigators are hoping to determine if adjusting radiation treatments based on daily MRI has a feasible way to deliver radiation for participants with pancreatic, lung or renal cancer.

Condition Malignant neoplasm of prostate, Pancreatic Cancer, Pulmonary Disease, urinary tract neoplasm, Malignant neoplasm of kidney, Nephropathy, Cancer, Prostatic disorder, Second Malignancy, Lung Neoplasm, Mesothelioma, Bronchial Neoplasm, Mesothelioma, synchronous neoplasms, Prostate Disorders, Liver Metastases, Kidney Disease (Pediatric), Cancer/Tumors, Prostate Cancer, Early, Recurrent, Brain Metastasis, Spinal Metastases, Malignant Mesothelioma, Brain Metastases, Ewing's Family Tumors, Liver Metastasis, Spine Metastases, Secondary Malignant Neoplasm of Liver, Hepatic Metastases, Cancer (Pediatric), Islet Ce417ll Cancer, Kidney Cancer, Lung Cancer, Prostate Cancer, Kidney Disease, Lung Disease, Neoplasms, Renal Cancer, Urologic Cancer, prostate carcinoma, adrenal metastases, second malignancies, cancer of the pancreas, cancer, renal, prostate cancers, pancreatic cancers, cancer, pancreatic, carcinoma lung, lung carcinoma, Oligoprogressive, Borderline Resectable Pancreatic Carcinoma, Oligoprogressive Nodal Metastases, Metachronous Nodal Metastases, Synchronous Nodal Metastases
Treatment MR-guided Linac
Clinical Study IdentifierNCT04115254
SponsorDana-Farber Cancer Institute
Last Modified on5 October 2021


Yes No Not Sure

Inclusion Criteria

Participants must have a confirmed malignancy requiring stereotactic body radiation therapy. See specific disease site cohorts for more details
Tumor size 7cm
Age 18 years of older
ECOG performance status 2 (Karnofsky 60%, see Appendix A)
Ability to understand and the willingness to sign a written informed consent document
Specific eligibility requirements for each disease site with be covered in each specific cohort

Exclusion Criteria

Specific exclusion requirements for each disease site with be covered in each specific cohort
History of allergic reactions attributed to gadolinium-based IV contrast
\-- Note: If a patient will not receive contrast, this is not applicable
Pregnant women are excluded from this study
Severe claustrophobia or anxiety
Participants who cannot undergo an MRI
Clear my responses

How to participate?

Step 1 Connect with a study center
What happens next?
  • You can expect the study team to contact you via email or phone in the next few days.
  • Sign up as volunteer to help accelerate the development of new treatments and to get notified about similar trials.

You are contacting

Investigator Avatar

Primary Contact



Additional screening procedures may be conducted by the study team before you can be confirmed eligible to participate.

Learn more

If you are confirmed eligible after full screening, you will be required to understand and sign the informed consent if you decide to enroll in the study. Once enrolled you may be asked to make scheduled visits over a period of time.

Learn more

Complete your scheduled study participation activities and then you are done. You may receive summary of study results if provided by the sponsor.

Learn more

Similar trials to consider


Browse trials for

Not finding what you're looking for?

Every year hundreds of thousands of volunteers step forward to participate in research. Sign up as a volunteer and receive email notifications when clinical trials are posted in the medical category of interest to you.

Sign up as volunteer

user name

Added by • 



Reply by • Private

Lorem ipsum dolor sit amet consectetur, adipisicing elit. Ipsa vel nobis alias. Quae eveniet velit voluptate quo doloribus maxime et dicta in sequi, corporis quod. Ea, dolor eius? Dolore, vel!

  The passcode will expire in None.

No annotations made yet

Add a private note
  • abc Select a piece of text from the left.
  • Add notes visible only to you.
  • Send it to people through a passcode protected link.
Add a private note